Target type: biologicalprocess
The controlled release of a Wnt protein from a cell. [GOC:bf, PMID:19223472]
Wnt proteins are a family of secreted signaling molecules that play crucial roles in development, tissue homeostasis, and disease. Their secretion is a complex process involving multiple steps and protein interactions.
**1. Synthesis and Processing:**
- Wnt proteins are synthesized in the endoplasmic reticulum (ER) as precursor proteins.
- They undergo glycosylation and palmitoylation modifications in the ER, which are essential for their proper folding and secretion.
- After modification, Wnt proteins are transported to the Golgi apparatus.
**2. Packaging into Transport Vesicles:**
- In the Golgi, Wnt proteins are packaged into transport vesicles along with specific chaperones and accessory proteins.
- These chaperones, such as Wntless (WLS), play critical roles in stabilizing Wnt proteins and facilitating their secretion.
**3. Trafficking to the Plasma Membrane:**
- The transport vesicles containing Wnt proteins move to the plasma membrane, where they fuse with the cell membrane.
- This fusion event releases the Wnt proteins into the extracellular space.
**4. Interaction with Wntless (WLS):**
- Wnt proteins require interaction with WLS for their efficient secretion.
- WLS binds to Wnt proteins in the Golgi and escorts them to the plasma membrane.
- WLS acts as a molecular chaperone, preventing Wnt proteins from degradation and promoting their release.
**5. Release from the Cell:**
- Upon reaching the plasma membrane, Wnt proteins are released into the extracellular space through a process known as exocytosis.
- The precise mechanism of Wnt release is still under investigation, but it is believed to involve the formation of specialized vesicles called Wnt-containing vesicles.
**6. Activation and Signaling:**
- Once secreted, Wnt proteins can bind to their receptors on target cells, initiating downstream signaling pathways.
- Wnt signaling pathways regulate diverse cellular processes, including cell proliferation, differentiation, and migration.
**7. Regulation of Wnt Secretion:**
- Wnt secretion is tightly regulated by various factors, including cell type, developmental stage, and environmental cues.
- For instance, Wnt secretion can be modulated by signaling pathways, such as the Hedgehog and TGF-beta pathways.
- Dysregulation of Wnt secretion is implicated in various diseases, including cancer and developmental disorders.'
"
Protein | Definition | Taxonomy |
---|---|---|
Protein-serine O-palmitoleoyltransferase porcupine | A protein-serine O-palmitoleoyltransferase porcupine that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9H237] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
N-(6-methyl-1,3-benzothiazol-2-yl)-2-[(4-oxo-3-phenyl-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl)thio]acetamide | organic heterobicyclic compound; organonitrogen heterocyclic compound; organosulfur heterocyclic compound | ||
lgk974 | LGK974 : A carboxamide, the structure of which is that of acetamide substituted on carbon by a 2',3-dimethyl-2,4'-bipyridin-5-yl group and on nitrogen by a 5-(pyrazin-2-yl)pyridin-2-yl group. It is a highly potent, selective and orally bioavailable Porcupine inhibitor (a Wnt signalling inhibitor). LGK974: a potent and specific small-molecule inhibitor of Porcupine (PORCN) acyltransferase | bipyridines; pyrazines; pyridines; secondary carboxamide | Wnt signalling inhibitor |
wnt-c59 | 2-(4-(2-methylpyridin-4-yl)phenyl)-N-(4-(pyridin-3-yl)phenyl)acetamide: a PORCN acyltransferase inhibitor; structure in first source |